Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.

Human vaccines & immunotherapeutics - 1 Jan 2014

Hanna Michael G, Howard Jason, Vermorken Jan

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antibodies, Monoclonal
Share to Antigens, Neoplasm
Share to Cancer Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25483649
DOI: 10.4161/hv.28886
PMCID: PMC4514058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.PMID 25483649Read ↗

Toward understanding and exploiting tumor heterogeneitySemantic proximity Read ↗

Immunotherapy: personalizing tumour vaccines.Semantic proximity Read ↗

Heterogeneity of the tumor immune microenvironment and clinical interventionsSemantic proximity Read ↗

Tumor heterogeneity is fundamental to the tumor ecosystem.Semantic proximity Read ↗

Navigating the Challenge of Tumor Heterogeneity in Cancer TherapySemantic proximity Read ↗

Tumor heterogeneity and its implication for drug deliverySemantic proximity Read ↗

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.Semantic proximity Read ↗

Maintaining Tumor Heterogeneity in Patient-Derived Tumor XenograftsSemantic proximity Read ↗

Targeted therapies for killing tumor cells.Semantic proximity Read ↗

Persistent mutations render cancer cells susceptible to immunotherapy.Semantic proximity Read ↗

Cancer immunotherapy for metastasis: past, present and futureSemantic proximity Read ↗

Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.